← Browse by Condition
Medical Condition

infection

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for infection sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — infection Clinical Trials

How many clinical trials are currently recruiting for infection?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for infection, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for infection?
infection research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a infection clinical trial?
Eligibility criteria for infection trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
Centre Hospitalier Universitaire, Amiens 1 trial
Karius, Inc. 1 trial
Medical University of Graz 1 trial
Tampere University Hospital 1 trial

Recruiting Clinical Trials

NCT07203833
Recruiting
Diagnostic and Prognostic Evaluation of Vasorin During Septic Shock
Enrollment
144 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT07110636
Recruiting
Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
Enrollment
2,000 pts
Location
United States
Sponsor
Karius, Inc.
View Trial →
NCT07109856
Recruiting
The Peripheral(-Muscle) Oxygenation and Perfusion Score as a New Non-invasive Tool to Predict Elevations in C-reactive Protein Levels in Neonates
Enrollment
93 pts
Location
Austria
Sponsor
Medical University of Graz
View Trial →
NCT07575009 Phase 3
Recruiting
Continuous Antibiotic Infusion In Children
Enrollment
150 pts
Location
Finland
Sponsor
Tampere University Hospital
View Trial →

Related Conditions

vasorin (1) septic shock (1) shock (1) biomarker (1) infections bacterial (1) infections fungal (1) infection viral (1) parasitic disease (1) prematurity infections (1) nirs (1) near infrared spectroscopy (1) preterm neonates (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology